Categories in 2015

Teamwork plays a critical and growing role in high-quality anticoagulation care. This award will be given to an outstanding team that has made a significant contribution to patient care, treatment or anticoagulation management. It may be a multidisciplinary team, a group of healthcare professionals or a management team that has introduced significant advances in clinical practice, patient support (including links to social care), service quality or efficiency.

 

L.GB.03.2015.10437 March 2015

This award recognises gains in quality and productivity through cross-sector partnerships and can include local or national campaign activity. It aims to reward partnership initiatives that have facilitated new or improved services in anticoagulation care at any point along the patient pathway.

Eligibility: Entrants must be a partnership team made up of at least two organisations working across a minimum of two sectors (NHS/pharma/life sciences/charity). Entrants should demonstrate adherence to the ABPI and DH joint working guidelines.

 

L.GB.03.2015.10437 March 2015

This category recognises initiatives that have contributed to the enhancement of patient care and outcomes through:

  • Patient engagement
  • Use of communication 
  • Provision of patient services
  • Provision of information/services

 

L.GB.03.2015.10437 March 2015

This category recognises initiatives that have contributed to the enhancement of care for cancer patients with VTE and have increased cancer patients awareness of their risk of VTE. 

 

L.GB.03.2015.10437 March 2015

This category recognises initiatives that demonstrate the setting up of a service to deliver the appropriate use of NOACs

 

L.GB.03.2015.10437 March 2015

This category will be nominated and decided by the Quality in Care Anticoagulation judging panel and will recognise an individual who has made an outstanding contribution to anticoagulation therapy.

 


L.GB.03.2015.10437 March 2015

Is your work eligible for entry?

Programmes and initiatives should relate to the period January 2010 to December 2015.

Particular credit will be given to projects which demonstrate results having quality and/or efficiency benefits which could be replicated elsewhere, thereby having a greater impact than their initial focus.

 

L.GB.03.2015.10437 March 2015


  • KEY DATES FOR 2017 TO BE ANNOUNCED
QiC Anticoagulation is supported by: